reviewTop 1% cited
Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles
Molecular Psychiatry · 2007 · Vol. 13(1) · pp. 27–35
Henry A. Nasrallah✉(University of Cincinnati Medical Center)
Schizophrenia research and treatmentDiabetes Treatment and ManagementReceptor Mechanisms and SignalingQuetiapineOlanzapineZiprasidoneClozapineAripiprazoleAtypical antipsychoticRisperidoneAntipsychoticMedicineAmisulpride
MeSH terms
AnimalsBlood GlucoseHumansMetabolic DiseasesAntipsychotic AgentsSignal TransductionReceptors, Neurotransmitter
Citations
708
FWCI
18.21
field-weighted impact
References
92
Percentile
100%
vs. same field & year
Citations per year
References
Olanzapine versus Placebo and Haloperidol
Neuropsychopharmacology · 1996 · 785 citations
Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding
Psychopharmacology · 1996 · 1,157 citations
Atypical antipsychotics and weightgain — a systematic review
Acta Psychiatrica Scandinavica · 2000 · 407 citations
Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III
Schizophrenia Research · 2005 · 1,134 citations
A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls
Schizophrenia Research · 2005 · 530 citations
Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.
Journal of Pharmacology and Experimental Therapeutics · 1989 · 1,350 citations
Antipsychotic-Induced Weight Gain: A Comprehensive Research Synthesis
American Journal of Psychiatry · 1999 · 2,384 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.